Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Azoxymethane is a potent carcinogenic and neurotoxic small molecule used primarily in biological research. It is the oxide of azomethane and is particularly effective at inducing colon carcinoma in laboratory animals, especially rodents. Azoxymethane acts as a DNA-damaging agent by inducing O6-methylguanine adducts in DNA, leading to G→A transitions and subsequent tumorigenesis. It is widely used to create animal models for studying the mechanisms of colon cancer progression and chemoprevention strategies[1][2][4][5][8]. Azoxymethane is not approved for human use; it serves exclusively as a research tool.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on azoxymethane.